Welcome to the gynecological research group
Gynecological cancer comprise the following programs:
Uterine cancer and cervical cancer, ovarian cancer, vaginal cancer and choriocarcinoma.
The programs are gathered in a complete treatment clinic, which includes surgery, chemo- hormone- and radiation therapy.
The department is a national centre of competence for gynecological oncology.
Our research focus on:
- Ovarian cancer
This project is supported by Mr. John Fredriksen and Ms. Inger Fredriksen Foundation
- Endometrial cancer
- Team members: Tropé, Kristensen, Danielsen, Abeler, Risberg, Manohar
Research goals
- Develop our role as the strongest research milieu in the country on gyncogological oncology with an extensive international interface
- Clinical medicamental research: A number of ongoing studies, partly together with cooperative clinical study organizations like NSGO, EORTC, MRC and GCIG.
- Translation research within ovarian cancer, endometrial cancer, cervical cancer and vulva cancer. Collaboration projects with the Institute for cancer research.
- Collaboration project with the Cancer Registry of Norway : prospective quality register at ovarian cancer
- Develop ultramodern molecular biology laboratory for ovarian cancer patients
- Pre-operative molecular biological and dynamic MR report at endometrial cancer
- Oncolex: Oncolex is a reference work for oncologic health personnel where you will find background information and updated procedures in diagnostics, cancer treatment and results. Web site www.oncolex.no will provide information related to the treatment and results of cervix, endometrium, ovarium and vulva cancer
- Cytostatica manual: A comprehensive booklet with practical guidelines to all chemocourses given to gynecologic oncologic patients in Norway.
Christos Samakovlis: The molecular basis of airway maturation in Drosophila
Jan 17, 2012
Latest publications
Gynecological oncology
Rab25 is overexpressed in Müllerian serous carcinoma compared to malignant mesothelioma
Virchows Arch (in press)
PubMed 22249560
A phase 3 trial of bevacizumab in ovarian cancer
N Engl J Med, 365 (26), 2484-96
PubMed 22204725
Genomic imbalances in endometrial adenocarcinomas - Comparison of DNA ploidy, karyotyping and comparative genomic hybridization
Mol Oncol, 6 (1), 98-107
PubMed 22062770





Print this page
